CurrentRheuma coverage · page 17 of 22

Clinical and Experimental Rheumatology

Briefs 641–680 of 849 CurrentRheuma has covered from this journal, newest publication first

Latest from Clinical and Experimental Rheumatology

All coverage, newest first

Clin Exp Rheumatol2 Mar 2023
Anti-TNF-α induced paradoxical psoriasis in patients with ankylosing spondylitis: a systematic review
Meta-analysisSpondyloarthritis & PsA
Clin Exp Rheumatol2 Mar 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
Guideline or statementAcross diseases
Clin Exp Rheumatol1 Mar 2023
Two emerging phenotypes of atypical inclusion body myositis: illustrative cases
Cohort studyMyositis
Clin Exp Rheumatol1 Mar 2023
Application of logistic regression and machine learning methods for idiopathic inflammatory myopathies malignancy prediction
Cohort studyMyositis
Clin Exp Rheumatol1 Mar 2023
Long-term survival of patients with idiopathic inflammatory myopathies: anatomy of a single-centre cohort
Cohort studyMyositis
Clin Exp Rheumatol1 Mar 2023
Skin biopsy analysis of concurrent keloidal morphoea and systemic sclerosis confirms overlapping pathogenic pathways
Mechanistic studySystemic sclerosis
Clin Exp Rheumatol1 Mar 2023
The diagnostic value of serum YKL-40 for myocardial involvement in immune-mediated necrotising myopathy
Diagnostic or prognostic studyMyositis
Clin Exp Rheumatol27 Feb 2023
Correlation between angiotensin-converting-enzyme 2 gene polymorphisms and systemic sclerosis
Research articleSystemic sclerosis
Clin Exp Rheumatol25 Feb 2023
The prevalence of pulmonary arterial hypertension in patients with mixed connective tissue disease: a systematic review and meta-analysis
Meta-analysisSjögren's & overlap
Clin Exp Rheumatol24 Feb 2023
Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry
Cohort studyRA
Clin Exp Rheumatol23 Feb 2023
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 study
Randomized controlled trialSpondyloarthritis & PsA
Clin Exp Rheumatol22 Feb 2023
Six medico-psycho-social dimensions of a pedagogical model used to define clusters of patients with Sjögren's syndrome and intentionality to participate in a patient education programme
Cross-sectional studySjögren's & overlap
Clin Exp Rheumatol21 Feb 2023
Treatment of systemic sclerosis-associated digital ulcers: recommendations of the Turkish Society for Rheumatology
Guideline or statementSystemic sclerosis
Clin Exp Rheumatol16 Feb 2023
The epidemiology of pathologically confirmed clinically isolated aortitis: a North American population-based study
Cohort studyVasculitis & PMR
Clin Exp Rheumatol15 Feb 2023
A Canadian vasculitis patient-driven survey to highlight which prednisone-related side effects matter the most
Cross-sectional studyVasculitis & PMR
Clin Exp Rheumatol15 Feb 2023
Elevated monocyte distribution width in patients with active adult-onset Still's disease: a novel activity indicator
Cross-sectional studyAutoinflammatory & rare
Clin Exp Rheumatol10 Feb 2023
Autologous fat or adipose-derived stem cells grafting in systemic sclerosis treatment: a systematic review and meta-analysis
Meta-analysisSystemic sclerosis
Clin Exp Rheumatol8 Feb 2023
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs
Cohort studySpondyloarthritis & PsA
Clin Exp Rheumatol7 Feb 2023
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia
Cross-sectional studySpondyloarthritis & PsA
Clin Exp Rheumatol7 Feb 2023
Association of polycyclic aromatic hydrocarbons with osteoarthritis among adults: an analysis of the NHANES 2001-2016
Cross-sectional studyOsteoarthritis
Clin Exp Rheumatol3 Feb 2023
Evaluation of clinical outcomes in systemic juvenile idiopathic arthritis patients treated with biological agents in Turkey: the TURSIS study
Cohort studyPediatric
Clin Exp Rheumatol2 Feb 2023
Expansion and surface makers of age-associated B cells in IgG4-related disease
Mechanistic studyAutoinflammatory & rare
Clin Exp Rheumatol1 Feb 2023
DAS28(3)CRP is a reliable measure of disease activity in pregnant women with rheumatoid arthritis
Cohort studyRA
Clin Exp Rheumatol30 Jan 2023
Role of Patrick-FABER test in detecting sacroiliitis and diagnosing spondyloarthritis in subjects with low back pain
Diagnostic or prognostic studySpondyloarthritis & PsA
Clin Exp Rheumatol19 Jan 2023
Prevalence of STAT3 mutations in patients with rheumatoid arthritis-associated T-cell large granular lymphocytic leukaemia and Felty syndrome
Cross-sectional studyRA
Clin Exp Rheumatol17 Jan 2023
Elevated serum uric acid is associated with renal arteriolopathy and predict poor outcome in patients with lupus nephritis
Cohort studyLupus & APS
Clin Exp Rheumatol13 Jan 2023
Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience
Cohort studyMyositis
Clin Exp Rheumatol12 Jan 2023
Mental health symptoms in scleroderma during COVID-19: a Scleroderma Patient-centred Intervention Network (SPIN) cohort longitudinal study
Cohort studySystemic sclerosis
Clin Exp Rheumatol7 Jan 2023
Sleep quality and predictors of optimal sleep in patients with rheumatoid arthritis: data from a recent-onset cohort
Cohort studyRA
Clin Exp Rheumatol6 Jan 2023
JAK/STAT inhibition modifies the ILC1 immune response in patients with rheumatoid arthritis
Mechanistic studyRA
Clin Exp Rheumatol5 Jan 2023
Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on immunoglobulin levels and risk for infections
Cohort studyPediatric
Clin Exp Rheumatol3 Jan 2023
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort
Cohort studySpondyloarthritis & PsA
Clin Exp Rheumatol26 Dec 2022
ANCA-associated pulmonary-renal syndrome treated with cyclophosphamide, rituximab, repeated methyl-prednisolone pulses and a reduced oral glucocorticoid regime: an observational study
Cohort studyVasculitis & PMR
Clin Exp Rheumatol22 Dec 2022
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based study
Cross-sectional studyFibromyalgia & pain
Clin Exp Rheumatol16 Dec 2022
Serological markers of basement membrane collagen type IV and laminin are increased in systemic lupus erythematosus but differentially expressed in patients with previous cardiovascular events
Cross-sectional studyLupus & APS
Clin Exp Rheumatol15 Dec 2022
Blood transcriptome and machine learning identified the crosstalk between COVID-19 and fibromyalgia: a preliminary study
Mechanistic studyFibromyalgia & pain
Clin Exp Rheumatol11 Dec 2022
Soluble Tyro-3 and Axl may reflect the current activity and the renal involvement in patients with microscopic polyangiitis and granulomatosis with polyangiitis
Cohort studyVasculitis & PMR
Clin Exp Rheumatol7 Dec 2022
Absolute risk estimation of new-onset proteinuria in patients with systemic lupus erythematosus: a Danish nationwide cohort study
Cohort studyLupus & APS
Clin Exp Rheumatol4 Dec 2022
Factors affecting the discrepancy between patient and physician global assessment in early rheumatoid arthritis: The Ontario Best Practices Research Initiative
Cohort studyRA
Clin Exp Rheumatol2 Dec 2022
Hydroxychloroquine exposure reduces the risk of cardiovasular disease events in patients with hypertension or diabetes mellitus
Cohort studyAcross diseases

All 849 Briefs in ExploreShowing Briefs 641–680 of 849, newest first